当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析

春立医疗

(688236)

  

流通市值:10.97亿  总市值:53.09亿
流通股本:7929.47万   总股本:3.84亿

春立医疗(688236)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.61亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益279643.57万元,未分配利润118989.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产349481.81万元,负债69838.25万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入508,283,661.62380,130,570.92221,850,180.791,208,523,845.88
营业总成本449,469,327.29304,028,844.65164,450,441.62911,961,036.54
营业利润65,450,654.1782,286,192.4259,325,467.29305,975,463.53
利润总额66,164,634.1683,069,962.5560,164,568.65305,905,863.04
净利润61,008,648.4778,960,894.7855,107,063.21277,818,116.48
其他综合收益----
综合收益总额61,008,648.4778,960,894.7855,107,063.21277,818,116.48
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,858,861,848.082,993,697,416.932,899,501,388.963,005,359,817.46
非流动资产合计635,956,266.63639,208,735.06643,160,801.73644,201,107.42
资产总计3,494,818,114.713,632,906,151.993,542,662,190.693,649,560,924.88
流动负债合计600,748,118.94720,211,490.68514,691,217.05676,672,835.51
非流动负债合计97,634,331.7493,350,130.5893,682,889.8593,652,656.42
负债合计698,382,450.68813,561,621.26608,374,106.9770,325,491.93
归属于母公司股东权益合计2,794,809,881.52,817,641,135.162,932,666,469.622,877,466,853.34
股东权益合计2,796,435,664.032,819,344,530.732,934,288,083.792,879,235,432.95
负债和股东权益合计3,494,818,114.713,632,906,151.993,542,662,190.693,649,560,924.88
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计739,551,633.47448,447,449.41217,425,731.311,653,577,304.62
经营活动现金流出小计756,831,047.22517,505,337.93347,039,070.381,141,863,415.55
经营活动产生的现金流量净额-17,279,413.75-69,057,888.52-129,613,339.07511,713,889.07
投资活动现金流入小计1,583,044,407.921,421,477,402.73837,229,065.922,367,674,846.28
投资活动现金流出小计1,532,216,273.351,341,842,237.92753,500,759.372,449,231,066.83
投资活动产生的现金流量净额50,828,134.5779,635,164.8183,728,306.55-81,556,220.55
筹资活动现金流入小计----
筹资活动现金流出小计144,357,900.31554,400-121,334,040.5
筹资活动产生的现金流量净额-144,357,900.31-554,400--121,334,040.5
汇率变动对现金及现金等价物的影响1,677.481,282,812.94-4,213.37-4,213.37
现金及现金等价物净增加额-110,807,502.0111,305,689.23-45,889,245.89308,819,414.65
期末现金及现金等价物余额1,155,205,573.661,277,318,764.91,220,123,829.781,266,013,075.67
最新报告期:2024-11-18
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华安证券李婵,谭国超0.310.530.712024-11-18
华创证券郑辰,李婵娟0.370.730.912024-11-04
TOP↑